Mintiply Capital, a Dubai-based investment banking and corporate advisory firm, recently announced the launch of its new initiative to support healthcare, life sciences, and longevity companies seeking to enter and scale across the Gulf. The latest move aims to empower international sponsors with a single point of contact for institutional-level strategic advisory, market-entry guidance, capital structuring, and financial readiness support.
The announcement follows the recent establishment of Dubai’s Longevity Authority under the law issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum earlier this year. The Authority gives the UAE a dedicated institutional framework for longevity, wellness and advanced health, a first for the region. It will work to accelerate efforts to develop a world-class ecosystem that embraces the latest medical solutions, biotechnologies, and life sciences.
With a dedicated institutional framework now in place, global healthcare and longevity groups have a clear pathway into one of the world’s most ambitious health economies. The clear institutional framework, strong investor appetite and access to high-net-worth healthcare consumers further strengthen the case for entry. That clarity has already translated into a sharp rise in inbound interest from international healthcare, peptide and compounding pharmacy companies evaluating UAE market entry.
Amid this growing interest, Mintiply Capital is well positioned to support these companies on the back of its dedicated practice focused on the UAE longevity and advanced health wave. The firm holds multiple active mandates from South American healthcare sponsors, led by a Brazilian group expanding into the UAE. These mandates establish Mintiply Capital as a bridge between Latin American healthcare and the Gulf.
Sharing the firm’s vision to channel international healthcare capital and expertise into the UAE’s longevity economy, Hasnae Taleb, Managing Partner at Mintiply Capital, said, “The establishment of the Dubai Longevity Authority marks a turning point for the region. For the first time, international healthcare and longevity companies have a dedicated regulator and a clear pathway into one of the world’s most ambitious health economies.”
“We are seeing that translate directly into demand, with sponsors from Brazil and across South America coming to the UAE not to test the market but to build here. Our role is to make that happen properly: the right structure, the right licences, the right partners and the right capital. Mintiply Capital intends to be the bridge between Latin American healthcare and the Gulf and to help position Dubai as the global capital of longevity,” she added.
As an exclusive corporate advisor on UAE market entry, Mintiply Capital supports clients across the full lifecycle of expansion. The scope of its engagement includes the structuring of holding and operating companies, the design of the licensing framework, joint venture design, investor readiness and capital raising. Its current mandates cover distribution and trade across the GCC and MENA, as well as Dubai-based operating and pharmacy platforms linked to partnerships with leading Brazilian pharmaceutical manufacturers.
The firm’s advisory reach extends beyond transaction support. Mintiply Capital brings deep cross-border experience to complex strategic and financial decisions, with a team that has overseen portfolios exceeding $3.8 billion in assets under management and facilitated approximately USD 480 million in fund arrangements. Its capabilities span strategic and financial advisory, private capital advisory, corporate finance advisory, and regulatory strategy and licensing across UAE regimes, including ADGM, DIFC, VARA, and sector-specific frameworks.
The latest initiative reflects the firm’s mission to channel international healthcare capital and expertise into the UAE’s longevity economy and its vision of helping Dubai become the global capital of longevity. Mintiply Capital remains committed to supporting the businesses that choose the UAE as their base and to the country’s ambition to build a world-class health economy.
Healthcare, life sciences and longevity companies evaluating GCC expansion can engage Mintiply Capital for market entry and capital strategy, leveraging the firm’s dedicated practice, active mandates and on the ground regulatory insight to accelerate their entry into the region.
